PharmaCyte Biotech, Inc. SUBSCRIPTION AGREEMENT — SERIES A PREFERRED STOCKSubscription Agreement • December 23rd, 2019 • PharmaCyte Biotech, Inc. • Biological products, (no disgnostic substances) • Nevada
Kenneth L. Waggoner ("Subscriber"), on the terms and conditions set forth herein, hereby irrevocable submits this Subscription Agreement ("Subscription Agreement") to PharmaCyte Biotech, Inc., a Nevada corporation ("Company"), in connection with the issuance by the Company of one share of Series A Preferred Stock, par value $0.0001 per share, of the Company ("Series A Stock") at a purchase price of $1.00.
Voting Rights Agreement of PharmaCyte Biotech, Inc.Voting Rights Agreement • December 23rd, 2019 • PharmaCyte Biotech, Inc. • Biological products, (no disgnostic substances) • Nevada
This Voting Rights Agreement ("Agreement"), is made as of September 16, 2019 ("Effective Date"), by and among PharmaCyte Biotech, Inc., a Nevada corporation ("Corporation"), and the stockholder of the Corporation as set forth on the signature pages hereto (each, a "Stockholder" and collectively "Stockholders"). Each of the Corporation and each Stockholder may be referred to herein individually as a “Party” and collectively as the “Parties”.
